In another in vitro experiment, dabigatran inhibited thrombin and reduced the expression of NOX4, iNOS, and SOD in fruit flies, suggesting that thrombin inhibition can reduce oxidative stress, which may be beneficial for PD patients (Johnson et al., 2020). Here, NOX4 is linked to Parkinson disease.